Clinical perspectives on pulmonary systemic and macromolecular delivery

Area of Science:

• Pulmonary drug delivery
• Aerosol science
• Respiratory system pharmacology

Background:

• The lung's anatomical and physiological features, including large epithelial surface area, high vascularization, and thin alveolar epithelium, make it a prime site for drug administration for systemic disorders.
• Historically, challenges in inhalation drug therapy stemmed from an incomplete understanding of aerosol inhalation mechanics and particle deposition.
• Recent advancements in aerosol research have significantly improved the comprehension of particle inhalation and pulmonary deposition mechanisms.

Purpose of the Study:

• To review the physical and physiological factors influencing aerosol particle deposition in the respiratory tract.
• To highlight the requirements for optimizing pulmonary drug delivery to specific lung regions.
• To address the challenges and progress in lung-targeted drug administration via inhalation.

Main Methods:

• Review of physical properties of aerosol particles relevant to lung deposition.
• Analysis of physiological factors, including breathing patterns and pulmonary diseases, affecting drug delivery.
• Examination of various inhalation techniques and their efficacy in targeted lung delivery.

Main Results:

• Aerosol particle deposition is influenced by particle characteristics, drug properties, and patient physiology (e.g., breathing patterns).
• Understanding these factors is crucial for achieving reproducible and targeted drug deposition in specific lung regions.
• Significant progress in aerosol research over the past two decades has enhanced the understanding of inhalation dynamics.

Conclusions:

• Optimizing pulmonary drug delivery necessitates a thorough consideration of physical and physiological parameters.
• Effective aerosol inhalation therapy relies on precise control over particle behavior and respiratory system interactions.
• Further research and application of current knowledge can improve the efficacy of lung-targeted drug therapies.